Abstract:
AIM: A series of derivatives were designed to identify the distribution of molecular field energies in the cavity and to testify the reliability of the model of Lanosterol 14α demethylase of
Candida albicans. METHODS: All of the 18 title compounds were synthesized and confirmed by elementary analysis,
1HNMR and IR spctrum. Some were confirmed further by
13CNMR, MS-EI and high-resolution MS spectrum. Their antifungal activities were evaluated
in vitro against 8 common human pathogenic fungi. RESULTS: All the compounds, except JS1a, JS5a, JS5b, JS5c, were first reported, while all of 18 title compounds were first reported as antifungal agents. CONCLUSION: Antifungal activities of the derivatives were in accord with the distribution of molecular field energies in the cavity, and the reliability of the model was validated by way of ligand design.